HCA
AMPH icon

Harbor Capital Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Harbor Capital Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8K Hold
391
– – ﹤0.01% 1031
2026
Q1 		$8K Buy
391
+120
+44% +$2.94K ﹤0.01% 1023
2025
Q4 		$7K Sell
271
-5
-2% -$129 ﹤0.01% 1031
2025
Q3 		$7K Buy
276
+10
+4% +$258 ﹤0.01% 1040
2025
Q2 		$6K Buy
266
+39
+17% +$968 ﹤0.01% 1093
2025
Q1 		$7K Buy
+227
New +$7.25K ﹤0.01% 1060

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DA
Denali Advisors San Diego, California $993M AUM 34.77% 1-Year Est. Return
BCC
Bridge City Capital Lake Oswego, Oregon $438M AUM 64.84% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Harbor Capital Advisors's AMPH Position: Q2 2026 in Review

Harbor Capital Advisors held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 391 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1031.

Harbor Capital Advisors first reported a position in AMPH in Q1 2025 and has held it in 6 quarters since. 101 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Harbor Capital Advisors held 391 shares of Amphastar Pharmaceuticals worth $8K as of Q2 2026.
  • Harbor Capital Advisors left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #1031 holding.
  • Harbor Capital Advisors first reported a position in Amphastar Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 101 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.